Global Newborn Calf Serum Market, By Origin (New Zealand Origin, U.S. Origin, Australia Origin, and Others), By Application (Drug Discovery, Cell Media Culture, and Others), By End User (Biotechnology & Pharmaceutical Industries, Academic Institutes, and Others (Research labs and Diagnostic Labs, etc.)), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 – 2027.
Global Newborn Calf Serum Market
Global Newborn Calf Serum Market was valued at USD 220.2 million in 2021 which expected to reach at USD 1201.4 million by 2027, at a CAGR 6.5% from 2022-2027.
Newborn Calf Serum is developed from 3 -10 days old calves. It is cheaper & better in quality than fetal bovine serum. As newborn calf serum is more affordable & commonly available, NBCS is preferred as a basal growth medium over fetal bovine serum. When a cell line is tough & cell attachment is a major concern during cell culture, newborn calf serum is often used. 
Market Drivers
The increase in investments by pharmaceutical company expected to fuel the growth of global newborn calf serum market over the forecast period. Key players are investing in manufacturing unit to increase their manufacturing capacity, this is projected to drive the growth of global newborn calf serum market. For instance, in January 2018, Indian Immunologicals Limited, an animal & human vaccine manufacturer introduced its new manufacturing plant with wholly owned its subsidiary Pristine Biologicals (NZ) Ltd. in New Zealand with the investment around US$1 million. Among all the product, newborn calf serum is one of the key products developed by this new manufacturing plant. 
Newborn calf serum is main ingredient in cell culture. Key players are investing in large scale in cell culture research. Companies are expanding their services toward cell therapy; therefore, these factors are expected to increase the use of newborn calf serum in future which will propel the growth of global newborn calf serum market.
Market Restraints
Stringent rules and regulations may hinder the global newborn calf serum market growth over the forecast period. Animal ethical committees are putting limitations to the use of newborn calf serum for the production of vaccines, which may hamper the global newborn calf serum market. 
Market Segmentation
The Global Newborn Calf Serum Market is segmented into origin such as New Zealand Origin, U.S. Origin, Australia Origin, Others. By application, market is segmented into Drug Discovery, Cell Media Culture. By end user, market is segmented into Biotechnology & Pharmaceutical Industries, Academic Institutes, Others.
Regional Analysis
The Global Newborn Calf Serum Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North America newborn calf serum market is expected to hold a dominant position throughout the forecast period due to the rise in vaccine production. For instance, in 2019, Merck & Company, a pharmaceutical company increased its overall vaccine supply to 190 million doses across the globe. 
Key Players
Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, HiMedia Laboratories, Atlas Biologicals, Inc., Bovogen Biologicals Pty Ltd., Novus Biologicals, LLC, Capricorn Scientific, PAN-Biotech GmbH, Atlanta Biologicals, Inc., etc.
Market Taxonomy
By Origin
•        New Zealand Origin
•        U.S. Origin
•        Australia Origin
•        Others
By Application
•        Drug Discovery
•        Cell Media Culture
By End User
•        Biotechnology & Pharmaceutical Industries
•        Academic Institutes
•        Others
By Region
•        North America
•        Latin America
•        Europe
•        Asia Pacific
•        Middle East & Africa

Global Newborn Calf Serum Market TOC:
1 Introduction        
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Newborn Calf Serum Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Newborn Calf Serum Market, By Origin
5.1 Y-o-Y Growth Comparison, By Origin 
5.2 Global Newborn Calf Serum Market Share Analysis, By Origin 
5.3 Global Newborn Calf Serum Market Size and Forecast, By Origin
5.3.1 New Zealand Origin
5.3.2. U.S. Origin
5.3.3. Australia Origin
5.3.4. Others
6 Global Newborn Calf Serum Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Newborn Calf Serum Market Share Analysis, By Application
6.3 Global Newborn Calf Serum Market Size and Forecast, By Application
6.3.1 Drug Discovery
6.3.2. Cell Media Culture
7 Global Newborn Calf Serum Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Newborn Calf Serum Market Share Analysis, By End User
7.3 Global Newborn Calf Serum Market Size and Forecast, By End User
7.3. 1 Biotechnology & Pharmaceutical Industries
7.3.2. Academic Institutes
7.3.3. Others
8 Global Newborn Calf Serum Market, By Region
8.1 Global Newborn Calf Serum Market Share Analysis, By Region
8.2 Global Newborn Calf Serum Market Share Analysis, By Region
8.3 Global Newborn Calf Serum Market Size and Forecast, By Region
9 North America Newborn Calf Serum Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America Newborn Calf Serum Market Share Analysis, By Origin
9.3 North America Newborn Calf Serum Market Size and Forecast, By Application
9.4 North America Newborn Calf Serum Market Size and Forecast, By End User
9.5 North America Newborn Calf Serum Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Newborn Calf Serum Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe Newborn Calf Serum Market Share Analysis, By Origin 
10.3 Europe Newborn Calf Serum Market Size and Forecast, By Application 
10.4 Europe Newborn Calf Serum Market Size and Forecast, By End User
10.5 Europe Newborn Calf Serum Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific Newborn Calf Serum Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific Newborn Calf Serum Market Share Analysis, By Origin 
11.3 Asia Pacific Newborn Calf Serum Market Size and Forecast, By Application 
11.4 Asia Pacific Newborn Calf Serum Market Size and Forecast, By End User
11.5 Asia Pacific Newborn Calf Serum Market Size and Forecast, By Country
11.5.1 China        
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America Newborn Calf Serum Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America Newborn Calf Serum Market Share Analysis, By Origin 
12.3 Latin America Newborn Calf Serum Market Size and Forecast, By Application 
12.4 Latin America Newborn Calf Serum Market Size and Forecast, By End User
12.5 Latin America Newborn Calf Serum Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East Newborn Calf Serum Market Analysis and Forecast (2022-2027)
13.1 Introduction
 13.2 Middle East Newborn Calf Serum Market Share Analysis, By Origin 
13.3 Middle East Newborn Calf Serum Market Size and Forecast, By Application 
13.4 Middle East Newborn Calf Serum Market Size and Forecast, By End User
13.5 Middle East Newborn Calf Serum Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Thermo Fisher Scientific Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Sartorius AG
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Merck KGaA
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 HiMedia Laboratories
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Atlas Biologicals, Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Bovogen Biologicals Pty Ltd
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Novus Biologicals, LLC
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies        
15.8 Capricorn Scientific
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 PAN-Biotech GmbH
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Atlanta Biologicals, Inc
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies